Pulmonary disposition of vancomycin in critically ill patients

被引:0
|
作者
H. Georges
O. Leroy
S. Alfandari
B. Guery
M. Roussel-Delvallez
C. Dhennain
G. Beaucaire
机构
[1] Hôpital Chatilliez,Service Universitaire de Réanimation Médicale et Maladies Infectieuses
[2] Lille University Medical School,Laboratoire de Bacteriologie, Hôpital A. Calmette
[3] Hôpital Chatilliez,Laboratoire de Bacteriologie
关键词
Internal Medicine; Pneumonia; Plasma Concentration; Plasma Level; Minimum Inhibitory Concentration;
D O I
暂无
中图分类号
学科分类号
摘要
Vancomycin penetration in epithelium lining fluid was studied in ten mechanically ventilated patients with methicillin-resistantStaphylococcus aureus pneumonia 24 hours after the onset of treatment. Vancomycin was given intravenously at a daily dose of 30 mg/kg. Vancomycin levels were detectable in four patients (range, 1–2.77 μg/ml). Concordance between high plasma concentrations (> 20 μg/ml) and detectable vancomycin levels in epithelium lining fluid was noted. These results suggest that the pulmonary disposition of vancomycin remains low for most patients 24 h after the onset of treatment compared with the minimum inhibitory concentrations for most gram-positive organisms. One therapeutic goal of vancomycin treatment could be to obtain through plasma levels of 20 μg/ml. Further studies are required to determine the clinical relevance of these observations.
引用
收藏
页码:385 / 388
页数:3
相关论文
共 50 条
  • [1] Pulmonary disposition of vancomycin in critically ill patients
    Georges, H
    Leroy, O
    Alfandari, S
    Guery, B
    RousselDelvallez, M
    Dhennain, C
    Beaucaire, G
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (05) : 385 - 388
  • [2] PHARMACOKINETIC CHARACTERISTICS OF VANCOMYCIN IN THE TREATMENT OF CRITICALLY ILL PATIENTS WITH PULMONARY INFECTIONS
    Zheng, Qingxia
    Liu, Liping
    Ma, Xiaowei
    Yang, Rui
    [J]. FARMACIA, 2017, 65 (04) : 610 - 616
  • [3] VANCOMYCIN PHARMACOKINETICS IN CRITICALLY ILL PATIENTS
    GARAUD, JJ
    REGNIER, B
    INGLEBERT, F
    FAURISSON, F
    BAUCHET, J
    VACHON, F
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 : 53 - 57
  • [4] Albumin disposition in critically Ill patients
    Erstad, Brian L.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (05) : 746 - 751
  • [5] DISPOSITION OF PHENYTOIN IN CRITICALLY ILL PATIENTS
    BOUCHER, BA
    RODMAN, JH
    FABIAN, TC
    CUPIT, GC
    LUDDEN, TM
    RAY, MW
    WEST, ME
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (06): : 473 - 473
  • [6] DISPOSITION OF PHENYTOIN IN CRITICALLY ILL TRAUMA PATIENTS
    BOUCHER, BA
    RODMAN, JH
    FABIAN, TC
    CUPIT, GC
    LUDDEN, TM
    WEST, ME
    RAY, MW
    [J]. CLINICAL PHARMACY, 1987, 6 (11): : 881 - 887
  • [7] PHENYTOIN(P) DISPOSITION IN CRITICALLY ILL PATIENTS
    BOUCHER, BA
    RODMAN, JH
    JARESKO, GS
    CUPIT, GC
    WATRIDGE, CB
    FABIAN, TC
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 135 - 135
  • [8] Initial dosing of vancomycin in critically ill patients
    Kees, Martin G.
    Voegeler, Stephan
    Hilpert, Justus W.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (01) : 91 - 92
  • [9] VANCOMYCIN PHARMACOKINETICS IN CRITICALLY ILL SURGERY PATIENTS
    MANN, HJ
    KUBAJAK, CAM
    FUHS, DW
    STATINE, JE
    CERRA, FB
    [J]. PHARMACOTHERAPY, 1988, 8 (02): : 122 - 122
  • [10] ANALYSIS OF VANCOMYCIN ENTRY INTO PULMONARY LINING FLUID BY BRONCHOALVEOLAR LAVAGE IN CRITICALLY ILL PATIENTS
    LAMER, C
    DEBECO, V
    SOLER, P
    CALVAT, S
    FAGON, JY
    DOMBRET, MC
    FARINOTTI, R
    CHASTRE, J
    GIBERT, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) : 281 - 286